Sunthetics, a pioneering AI technology company, has successfully closed a $4 million Seed round, led by L’ATTITUDE Ventures and supported by S3 Ventures, Hearst Level Up Ventures, and the Global Impact Fund II. The funding will support the expansion of Sunthetics’ team and enhance its machine learning platform, designed to revolutionize the pharmaceutical and chemical research and development (R&D) processes by drastically reducing time-to-market and R&D costs.
1. Sunthetics Secures $4 Million in Seed Funding
- Sunthetics raised $4 million to accelerate the growth of its AI-driven platform, which is transforming the pharmaceutical and chemical industries.
- The investment is backed by L’ATTITUDE Ventures, S3 Ventures, Hearst Level Up Ventures, and the Global Impact Fund II.
2. Empowering the Pharmaceutical and Chemical Industries with AI
- Founded by Daniela Blanco, Sunthetics leverages machine learning to optimize R&D in the chemical and pharmaceutical industries.
- The platform utilizes small datasets (as few as five data points) to guide experimentation and identify viable product pathways with high efficiency.
3. Accelerating R&D Processes and Reducing Costs
- Sunthetics’ AI-powered platform drastically cuts the time required for product development while reducing R&D costs, allowing companies to bring products to market faster.
- Customers, including top pharmaceutical and chemical companies, have reported up to 6x faster process development, a 75% reduction in material costs, and a 12% increase in efficiency.
4. Focus on Sustainability and Innovation
- L’ATTITUDE Ventures is particularly excited about Sunthetics’ commitment to sustainability, as its platform not only accelerates product development but also encourages more sustainable practices in the industry.
- Sunthetics is leading the way in AI-optimized chemical process development, setting new standards for R&D speed and sustainability.
5. Vision for the Future
- Sunthetics plans to use this investment to accelerate product development and market adoption, helping to drive the chemical industry’s digital transformation and the rise of automated experimentation.
- CEO Daniela Blanco expresses immense pride in her visionary team and their ability to change the landscape of the chemical industry through innovation and AI.
Sunthetics is positioning itself as a leader in AI-driven chemical and pharmaceutical research. With the support of strategic investors, the company is accelerating its growth and product development to reshape industries, drive faster and more sustainable R&D processes, and foster innovation in the chemical sector.
